London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’

14 juin 2026 | Julia Kollewe
Poolbeg Pharma to test the treatment in NHS hospitals and says it is also developing a GLP-1 weight loss pill A London-based startup is about to trial a drug at six NHS hospitals that could stop people on cancer immunotherapy getting a life-threatening side-effect. Poolbeg Pharma said its oral (…)
 Site référencé:  The Guardian (Asia Pacific)

The Guardian (Asia Pacific) 

UFC Freedom 250 : White House hosts MMA card for Trump’s 80th birthday amid dismal Canada and Obama jibes – live updates
15/06/2026
TV tonight : what goes on behind the scenes at OnlyFans ?
15/06/2026
Middle East crisis live : US and Iran say peace deal reached as European leaders warn Tehran ‘must never acquire a nuclear weapon’
15/06/2026
‘More relevant now than ever’ : how Virginia Woolf recaptured the cultural zeitgeist
15/06/2026
Disabled people with lifelong conditions facing ‘unnecessary’ Pip reassessments
15/06/2026
The Iran war has reached a tragic new phase : the fear, killing and upheaval are all normalised | Nesrine Malik
15/06/2026